Relationship between antiepileptic drugs and biological markers affecting long-term cardiovascular function in

Laura S Cheng1, Asuri N Prasad, Michael J Rieder

  • 1Department of Physiology and Pharmacology, University of Western Ontario, London, Ontario, Canada.

Insights

Long-term use of antiepileptic drugs (AEDs) in children with epilepsy may elevate homocysteine and lipoprotein levels, increasing cardiovascular disease risk. Further research is needed to understand these risks.

Area of Science:

  • Neurology
  • Pharmacology
  • Cardiovascular Science

Background:

  • Epilepsy is a common pediatric neurological disorder.
  • Children with epilepsy often undergo long-term treatment with antiepileptic drugs (AEDs).
  • Chronic AED exposure can alter plasma homocysteine and serum lipoprotein levels.

Purpose of the Study:

  • To review the cardiovascular effects of anticonvulsant therapy in childhood epilepsy.
  • To examine the role of homocysteine and lipoprotein concentrations in this context.

Main Methods:

  • Conducted a literature search of PubMed and MEDLINE databases (1966-May 2009).
  • Utilized keywords: antiepileptic drugs, epilepsy, homocysteine, cardiovascular events, children.

Main Results:

  • Specific AEDs (carbamazepine, phenobarbital, phenytoin, valproic acid) can elevate homocysteine and lipoprotein levels.
  • Genetic factors, such as 5-methylenetetrahydrofolate reductase polymorphism, may contribute to these elevations.

Conclusions:

  • Elevated homocysteine and lipoprotein are linked to long-term cardiovascular disease risk in children on AEDs.
  • Concerns exist regarding the chronic implications of AED use and cardiovascular risk in pediatric populations.
  • Further research is necessary to clarify the relationships between specific AEDs, biochemical markers, genotype, and long-term outcomes.
Abstract

Related Concept Videos

Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...